These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24522409)

  • 1. The impact of frailty on pharmacokinetics in older people: using gentamicin population pharmacokinetic modeling to investigate changes in renal drug clearance by glomerular filtration.
    Johnston C; Hilmer SN; McLachlan AJ; Matthews ST; Carroll PR; Kirkpatrick CM
    Eur J Clin Pharmacol; 2014 May; 70(5):549-55. PubMed ID: 24522409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gentamicin pharmacokinetics in old age and frailty.
    Hilmer SN; Tran K; Rubie P; Wright J; Gnjidic D; Mitchell SJ; Matthews S; Carroll PR
    Br J Clin Pharmacol; 2011 Feb; 71(2):224-31. PubMed ID: 21219402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous pharmacokinetic modeling of gentamicin, tobramycin and vancomycin clearance from neonates to adults: towards a semi-physiological function for maturation in glomerular filtration.
    De Cock RF; Allegaert K; Brussee JM; Sherwin CM; Mulla H; de Hoog M; van den Anker JN; Danhof M; Knibbe CA
    Pharm Res; 2014 Oct; 31(10):2643-54. PubMed ID: 24789450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of aminoglycoside dosing and estimated glomerular filtration rate in determining gentamicin and tobramycin area under the curve and clearance.
    Lim AK; Mathanasenarajah G; Larmour I
    Intern Med J; 2015 Mar; 45(3):319-29. PubMed ID: 25581282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis.
    Hodiamont CJ; Juffermans NP; Bouman CS; de Jong MD; Mathôt RA; van Hest RM
    Int J Antimicrob Agents; 2017 Feb; 49(2):204-211. PubMed ID: 28038961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics: development of a medical intensive care unit-specific gentamicin dosing nomogram.
    Watling SM; Kisor DF
    Ann Pharmacother; 1993 Feb; 27(2):151-4. PubMed ID: 8439687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia.
    Frymoyer A; Meng L; Bonifacio SL; Verotta D; Guglielmo BJ
    Pharmacotherapy; 2013 Jul; 33(7):718-26. PubMed ID: 23553582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of gentamicin in hospitalized patients receiving once-daily dosing.
    Xuan D; Nicolau DP; Nightingale CH
    Int J Antimicrob Agents; 2004 Mar; 23(3):291-5. PubMed ID: 15164971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily.
    Kirkpatrick CM; Duffull SB; Begg EJ
    Br J Clin Pharmacol; 1999 Jun; 47(6):637-43. PubMed ID: 10383541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.
    Roberts JA; Field J; Visser A; Whitbread R; Tallot M; Lipman J; Kirkpatrick CM
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3635-40. PubMed ID: 20547809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study.
    Nielsen EI; Sandström M; Honoré PH; Ewald U; Friberg LE
    Clin Pharmacokinet; 2009; 48(4):253-63. PubMed ID: 19492870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of population pharmacokinetic models of gentamicin in paediatric patients.
    Crcek M; Zdovc J; Kerec Kos M
    J Clin Pharm Ther; 2019 Oct; 44(5):659-674. PubMed ID: 31102287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of four renal function estimation equations for pharmacokinetic modeling of gentamicin in geriatric patients.
    Charhon N; Neely MN; Bourguignon L; Maire P; Jelliffe RW; Goutelle S
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1862-9. PubMed ID: 22290966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetic modelling of gentamicin and vancomycin in patients with unstable renal function following cardiothoracic surgery.
    Staatz CE; Byrne C; Thomson AH
    Br J Clin Pharmacol; 2006 Feb; 61(2):164-76. PubMed ID: 16433871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Pharmacokinetic Analysis of Gentamicin in Pediatric Extracorporeal Membrane Oxygenation.
    Moffett BS; Morris J; Galati M; Munoz FM; Arikan AA
    Ther Drug Monit; 2018 Oct; 40(5):581-588. PubMed ID: 29957666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rat model of early sepsis: relationships between gentamicin pharmacokinetics and systemic and renal effects of bacterial lipopolysaccharide combined with interleukin-2.
    Studena S; Martinkova J; Slizova D; Krs O; Senkerik M; Springer D; Chládek J
    Biol Pharm Bull; 2012; 35(10):1703-10. PubMed ID: 23037160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The performances of the Cockcroft-Gault, modification of diet in renal disease study and chronic kidney disease epidemiology collaboration equations in predicting gentamicin clearance.
    Chin PK; Florkowski CM; Begg EJ
    Ann Clin Biochem; 2013 Nov; 50(Pt 6):546-57. PubMed ID: 24045301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis.
    Teigen MM; Duffull S; Dang L; Johnson DW
    J Clin Pharmacol; 2006 Nov; 46(11):1259-67. PubMed ID: 17050791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gentamicin pharmacokinetics and pharmacodynamics during short-daily hemodialysis.
    Decker BS; Mohamed AN; Chambers M; Kraus MA; Moe SM; Sowinski KM
    Am J Nephrol; 2012; 36(2):144-50. PubMed ID: 22813936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No role for patient body weight on renal function assessment for drug dosing.
    Ariano RE; Zelenitsky SA; Poncsak KR; Davis JC; Vercaigne LM
    J Antimicrob Chemother; 2017 Jun; 72(6):1802-1811. PubMed ID: 28369383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.